A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.
A UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.
New studies show that many people see friends and family – and even pleasant strangers – as less of a COVID-19 risk, which partly explains why some people drop their guard with family and at social gatherings.
Many low-income immigrant adults in California avoid public assistance programs for fear of jeopardizing their immigration status, UCLA researchers say.
UC Davis Medical Center’s always popular peregrine family returns for its third season of being live streamed from the top of the hospital in Sacramento.
UC Davis employees, students and the public are invited to make Easter special for children hospitalized at UC Davis Children’s Hospital this year, by helping to provide Easter baskets filled with goodies. The UC Davis Child Life and Creative Arts Therapy Department is currently accepting donations for Easter basket supplies…
UC Davis Health today announced plans for an expansion of the UC Davis Medical Center with a project called ‘California Tower – part of the health system’s long-time commitment to improving health in local neighborhoods and across Northern California.
UC San Diego was awarded five COVID-19 Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health totaling nearly $33 million, which will fund efforts that range from managing a large data center to expanding testing in disadvantaged communities.
Health Media Contacts
Find the best contact for health-related media inquiries.
